Anzeige
Mehr »
Login
Samstag, 25.01.2025 Börsentäglich über 12.000 News von 683 internationalen Medien
Hinter dem nuklearen Ansturm im Silicon Valley: Eine strategische Chance entsteht
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
519 Leser
Artikel bewerten:
(2)

AMD Global Telemedicine Appoints Tim Steffl as New President

Finanznachrichten News

Leading the Next Era of Innovation and Growth for the Company

CHELMSFORD, MA / ACCESSWIRE / June 11, 2024 / AMD Global Telemedicine, a leader in telehealth solutions, is excited to announce the appointment of Tim Steffl as the new President. Tim joins the company with an extensive background in healthcare, bringing a wealth of experience and a strong track record of success. His leadership will be focused on driving AMD Global Telemedicine into a new era of innovation and growth.

Tim Steffl, Appointed President of AMD Global Telemedicine

Tim Steffl, Appointed President of AMD Global Telemedicine
Tim Steffl

Tim's distinguished career in healthcare spans several high-profile positions. He spent 16 years with the American Hospital Association (AHA), where he served as Chief Operating & Development Officer. In this role, he managed the for-profit endorsement arm of the AHA and was instrumental in founding, launching, and running three start-up organizations. His leadership and entrepreneurial spirit align perfectly with AMD Global Telemedicine's mission to innovate and enhance healthcare through digital health technologies.

Most recently, Tim was the President and CEO of the dental technology company ADA Business Innovation Group (ADABIG). He was responsible for establishing the profitability and scalable growth of this for-profit subsidiary of the American Dental Association. His role included developing a business portfolio of companies by partnering with, developing, or acquiring innovative organizations in the dental sector. Tim also created a strategy for growing and scaling ADA Practice Transitions, which helps match dentists looking to buy or sell a dental practice.

Tim also served as Vice President of Strategic Development & Finance at Delta Dental Plans Association. In this capacity, he provided strategic oversight and leadership across multiple functions, significantly contributing to the organization's growth and success. His deep understanding of the healthcare and technology landscape and his ability to drive strategic initiatives will be invaluable as he leads AMD Global Telemedicine.

Tim is also a dedicated Mentor at MATTER, a Chicago-based healthcare incubator and accelerator, where he offers business expertise to start-up organizations in the healthcare space. His commitment to fostering innovation and supporting emerging healthcare companies further demonstrates his alignment with the management team and AMD Global Telemedicine's vision.

"I am honored to join AMD Global Telemedicine and excited to lead the company in delivering innovative telehealth solutions," said Tim. "My focus will be on leveraging our cutting-edge technology to enhance patient care and streamline the delivery of healthcare. Together with the talented team at AMD, we will drive the future of telehealth and expand our impact on healthcare globally."

"We are thrilled to welcome Tim to the AMD Global Telemedicine family," said Lewis Miller, Board Member, AMD Global Telemedicine. "His extensive experience and proven leadership in the healthcare sector make him the ideal person to lead our company. We are confident that under his leadership, AMD Global Telemedicine will achieve new heights of success and continue to revolutionize telehealth solutions."

For more information about AMD Global Telemedicine, visit www.amdtelemedicine.com.

Contact Information:

Keri Souza
VP of Marketing
ksouza@amdtelemedicine.com
978-937-9021

SOURCE: AMD Global Telemedicine

.

View the original press release on newswire.com.

© 2024 ACCESS Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.